Apatinib, Irinotecan and S-1 (ApaIRIS) in Treating Patients With Metastatic Pancreatic Cancer After AG Regimen
Clinical trial NCT04101929 · UNKNOWN
Trial details
- NCT number
- NCT04101929
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-01
- Primary completion
- 2021-12-31
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.